Loading…
Aplysinopsin analogs: Synthesis and anti-proliferative activity of substituted ( Z)-5-( N-benzylindol-3-ylmethylene)imidazolidine-2,4-diones
A series of substituted ( Z)-5-( N-benzylindol-3-ylmethylene)imidazolidine-2,4-dione ( 3) analogs structurally related to aplysinopsin, and that incorporate a variety of substituents in both the indole and N-benzyl moieties have been synthesized under microwave irradiation and conventional heating m...
Saved in:
Published in: | Bioorganic & medicinal chemistry 2010-05, Vol.18 (10), p.3570-3574 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | A series of substituted (
Z)-5-(
N-benzylindol-3-ylmethylene)imidazolidine-2,4-dione (
3) analogs structurally related to aplysinopsin, and that incorporate a variety of substituents in both the indole and
N-benzyl moieties have been synthesized under microwave irradiation and conventional heating methods. These analogs were evaluated for their anti-proliferative activity against MCF-7 and MDA-231 breast cancer cell lines, and A549 and H460 lung cancer cell lines. Two analogs,
3f and
3j had IC
50 values of 4.4 and 5.2
μM, respectively, compared to 5-fluorouracil (IC
50
=
15.2
μM) against MCF-7 cells.
A series of substituted (
Z)-5-(
N-benzylindol-3-ylmethylene)imidazolidine-2,4-dione (
3) analogs structurally related to aplysinopsin, and that incorporate a variety of substituents in both the indole and
N-benzyl moieties have been synthesized under microwave irradiation and conventional heating methods These analogs were evaluated for their anti-proliferative activity against MCF-7 and MDA-231 breast cancer cell lines, and A549 and H460 lung cancer cell lines. Two analogs,
3f and
3j had IC
50 values of 4.4 and 5.2
μM, respectively, compared to 5-fluorouracil (IC
50
=
15.2
μM) against MCF-7 cells. |
---|---|
ISSN: | 0968-0896 1464-3391 |
DOI: | 10.1016/j.bmc.2010.03.054 |